Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,042 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,672 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07407452 | Iparomlimab and Tuvonralimab (QL1706) Combined With Standard Chemotherapy or Combined With Intraperitoneal Perfusion Chemotherapy and Olaparib as Neoadjuvant Therapy for Advanced Ovarian Cancer | not yet recruiting | Phase 2 | 50 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07407686 | Improving Engagement From Underserved Communities With Prostate Cancer Genetics Services(INCLUDE PC) | not yet recruiting | — | 100 | Royal Marsden NHS Foundation Trust |
| 0 |
| Feb 12, 2026 |
| clinicaltrials |
| NCT07401654 | The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin Combination as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 Expression | not yet recruiting | Phase 2 | 60 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Feb 10, 2026 | clinicaltrials |
| NCT07394413 | Surgical Handling of Fertility-preserving Treatments for Cervical Adenocarcinomas(SHAFT) | not yet recruiting | — | 100 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT07379905 | MODUCARE Versus Wait-and-See Approach for Histologically Proven Low-grade Cervical Intraepithelial Neoplasia (CIN1)(MODUCIN1) | not yet recruiting | N/A | 182 | Aristotle University Of ThessalonikiOTHER | 0 | Feb 5, 2026 | clinicaltrials |
| NCT07382479 | NeoAdjuvant ChemoTherapy With KELIM Guided Interval vs. Delayed Interval Debulking Surgery(NACT-KELIM ID) | not yet recruiting | N/A | 485 | Aristotle University Of ThessalonikiOTHER | 0 | Feb 5, 2026 | clinicaltrials |
| NCT07164534 | A Clinical Trial to Assess the Effectiveness of NRF2 Activator (Oral Sodium-copper- Chlophyllin ) in Locally Advanced Cervical Cancer to Reduce Late Radiotherapy Toxicity.(CHOC-LATE) | not yet recruiting | Phase 3 | 316 | Tata Memorial HospitalOTHER_GOV | 0 | Feb 4, 2026 | clinicaltrials |
| NCT07385976 | The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients | not yet recruiting | — | 100 | Far Eastern Memorial HospitalOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT07386171 | Micro-Ultrasound for Detecting Clinically Significant Prostate Cancer in Active Surveillance(MUS-AS) | not yet recruiting | N/A | 90 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT07386496 | The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI | not yet recruiting | N/A | 250 | Chinese University of Hong KongOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT07382713 | Fluzoparib Plus Famitinib Maintenance After First-Line Platinum Response in Advanced Ovarian Cancer | not yet recruiting | Phase 2 | 43 | Jinhua ZhouOTHER | 0 | Feb 3, 2026 | clinicaltrials |
| NCT07381582 | Safety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(161Tb-LNC1011) | not yet recruiting | Early Phase 1 | 15 | Peking Union Medical College HospitalOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07382505 | Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer | not yet recruiting | — | 600 | Asan Medical CenterOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07378371 | Proactive Temperature Management in CRS-HIPEC for Prevention of Delirium | not yet recruiting | N/A | 174 | Aerospace Center HospitalOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT07374809 | IMMUNOTHERAPY EFFICACY TARGETING ENDOMETRIAL CANCER(DEMETER) | not yet recruiting | N/A | 50 | European Institute of OncologyOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07376057 | Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer | not yet recruiting | — | 150 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07286162 | Trauma-Focused Managing Cancer And Living Meaningfully (CALM-TF) for Newly Diagnosed and Recurrent Ovarian Cancer(CALM-TF) | not yet recruiting | Phase 3 | 300 | University Health Network, TorontoOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT07368985 | Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer | not yet recruiting | Phase 2 | 87 | Prof. Dr. Remi A. NoutOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT07369986 | Immunotherapy for Surgery Avoidance in Vulnerable dMMR Endometrial Cancer(IMMUNE-SAVE) | not yet recruiting | Phase 2 | 30 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 0 | Jan 27, 2026 | clinicaltrials |
| NCT07370818 | To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian Cancer | not yet recruiting | Phase 2 | 81 | Onconic Therapeutics Inc.INDUSTRY | 1 | Jan 27, 2026 | clinicaltrials |
| NCT07363330 | A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer | not yet recruiting | Phase 2 | 32 | Zhongnan HospitalOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT07365397 | Imaging Characteristics of Different ⁶⁸Ga-PSMA Probes in Prostate Cancer | not yet recruiting | N/A | 9 | Shanghai Zhongshan HospitalOTHER | 0 | Jan 26, 2026 | clinicaltrials |
| NCT06811454 | Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET) | not yet recruiting | N/A | 76 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT07362147 | Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life | not yet recruiting | N/A | 74 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Jan 23, 2026 | clinicaltrials |
| NCT07066969 | Prevalence of Germline Alterations in Actionable Genes in Endometrial Cancer(GerEC) | not yet recruiting | N/A | 20 | European Institute of OncologyOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT07355010 | A Randomized, Open-label, Double-cohort Study of Fluzoparib Combined With Famitinib Malate or SHR-1701 for Neoadjuvant Therapy in Patients With Advanced Ovarian Cancer | not yet recruiting | Phase 2 | 104 | Qinglei GaoOTHER | 0 | Jan 21, 2026 | clinicaltrials |
| NCT07355504 | Prostate Cancer Early Detection Using Serial MRI Examinations(PROCEDE) | not yet recruiting | N/A | 380 | University Hospital, GrenobleOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07348861 | A Phase II Study of Neoadjuvant Sacituzumab Tirumotecan in Combination With Iparomlimab and Tuvonralimab in Locally Advanced Cervical Cancer | not yet recruiting | Phase 2 | 25 | Zheng MinOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT07240220 | The Mother-Daughter Project: Merck-4(Merck-4) | not yet recruiting | N/A | 2,500 | Indiana UniversityOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT07112612 | Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer | not yet recruiting | — | 50 | Anhui Medical UniversityOTHER | 0 | Jan 12, 2026 | clinicaltrials |
| NCT07333326 | Uterine Artery Doppler Flow Velocimetry Parameters for Predicting the Occurrence of Persistent Gestational Trophoblastic Neoplasia After Evacuation of Complete Hydatiform Mole | not yet recruiting | — | 175 | Minia UniversityOTHER | 0 | Jan 12, 2026 | clinicaltrials |
| NCT06660862 | Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer. | not yet recruiting | Phase 4 | 80 | University of ChicagoOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT07321730 | Surgeons' Ability to Predict Pathological and Molecular Features of Peritoneal Carcinomatosis in Ovarian Cancer(Visual-PC) | not yet recruiting | — | 50 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 0 | Jan 7, 2026 | clinicaltrials |
| NCT07311915 | Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study | not yet recruiting | N/A | 30 | Zhongda HospitalOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT07318701 | Multi-agent LLMs for Decision Support in Cervical Cancer During Pregnancy | not yet recruiting | N/A | 150 | Obstetrics & Gynecology Hospital of Fudan UniversityOTHER | 0 | Jan 6, 2026 | clinicaltrials |
| NCT07310355 | 68Ga-PSMA-0057 and 177Lu-PSMA-0057 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer | not yet recruiting | Phase 1 / Phase 2 | 49 | Chengdu StarRay Therapeutics Co., LtdINDUSTRY | 0 | Dec 30, 2025 | clinicaltrials |
| NCT07310433 | Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer | not yet recruiting | Phase 2 | 60 | Yung NAOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT07306260 | Multicenter Prospective Non-randomized Controlled Study of Ella Photodynamic Therapy for Cervical HSIL/CIN2(PDT for CIN2) | not yet recruiting | N/A | 560 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT07300566 | Focal Versus Whole Gland High Dose-Rate Brachytherapy (HDR-BT) Boost to External Beam Radiotherapy in Localized Prostate Cancer: A Phase 2 Randomized Trial(FORWARD) | not yet recruiting | Phase 2 | 58 | Joelle HelouOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT06799624 | Prognostic Role of molEcular classiFication in Fertility-sparing treAtment of Endometrial canCEr(PREFACE) | not yet recruiting | — | 100 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT07298707 | Cervical Cytology DNA Methylation for Endometrial Lesion Screening and Follow-up(EndoMethy-V) | not yet recruiting | — | 3,500 | Peking Union Medical College HospitalOTHER | 0 | Dec 23, 2025 | clinicaltrials |
| NCT07280897 | SCIPI Implementation and Evaluation: A Multi-site Proof-of-Concept Pilot Trial(SCIPI) | not yet recruiting | N/A | 200 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT07295132 | RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse) | not yet recruiting | Phase 2 | 160 | Asan Medical CenterOTHER | 0 | Dec 19, 2025 | clinicaltrials |
| NCT07291557 | PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer | not yet recruiting | Phase 2 | 250 | AHS Cancer Control AlbertaOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT07282197 | Darolutamide+ADT Post-RP w/o ePLND in hrPC: Briganti 2019 | not yet recruiting | Phase 2 | 40 | Peking University First HospitalOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT07069049 | Electroacupuncture in the Treatment of Patients Undergoing Transperineal Prostate Biopsy Under Local Anesthesia(EATPULA) | not yet recruiting | N/A | 190 | Shanghai University of Traditional Chinese MedicineOTHER | 0 | Dec 9, 2025 | clinicaltrials |
| NCT07271914 | PONDER: Pelvic Peritonectomy in Early Stage Ovarian Tumors(PONDER) | not yet recruiting | N/A | 390 | Ospedale Santa Croce-Carle CuneoOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT07272317 | PSMA-PET/MRI-Ultrasound Multimodal Fusion Navigation for Da Vinci Robot-Assisted Radical Prostatectomy: A Randomized Controlled Trial | not yet recruiting | N/A | 98 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT07273396 | Tolerance, Safety, Efficacy, and Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel for Platinum-resistant Recurrent Ovarian Cancer | not yet recruiting | Phase 1 / Phase 2 | 53 | Seoul National University HospitalOTHER | 0 | Dec 9, 2025 | clinicaltrials |
| NCT05077215 | Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer | not yet recruiting | Phase 3 | 450 | Evergreen Therapeutics, Inc.INDUSTRY | 0 | Dec 8, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Feb 12, 2026source: clinicaltrials